CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

Journal of Clinical Oncology - United States
doi 10.1200/jco.2007.12.5922
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

The CHEK2 1100delC Mutation Identifies Families With a Hereditary Breast and Colorectal Cancer Phenotype

American Journal of Human Genetics
Genetics
2003English

CHEK2 1100delC in Patients With Metachronous Cancers of the Breast and the Colorectum

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

Table 1: Baseline Characteristics of Controls and Breast Cancer Cases.

English

SNPs for Breast Cancer Risk Assessment

Oncotarget
Oncology
2017English

MTHFR C677T Polymorphism and Breast, Ovarian Cancer Risk: A Meta-Analysis of 19,260 Patients and 26,364 Controls

OncoTargets and Therapy
OncologyPharmacology
2017English

Association of APOBEC3 Deletion With Cancer Risk: A Meta-Analysis of 26 225 Cases and 37 201 Controls

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Adjuvant Bisphosphonate Treatment in Early Breast Cancer: Meta-Analyses of Individual Patient Data From Randomised Trials

The Lancet
Medicine
2015English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy